EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S Mutations

Behnoush Abedi-Ardekani, Doriane Gouas, Stephanie Villar, Masoud Sotoudeh, Pierre Hainaut

Hepatitis Research and Treatment · 2011

DOI: 10.1155/2011/475965 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatitis Research and Treatment, 2011. Verfasst von Behnoush Abedi-Ardekani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mechanisms of Carcinogenesis Section, Molecular Carcinogenesis Group, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyo…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High incidence of HCC is mostly due to the combination of two major risk factors, chronic infection with hepatitis B (HBV) and/or C (HCV) viruses and exposure to the mycotoxin aflatoxin B 1 , which induces a particular mutation at codon 249 in TP53 (R249S) . Eight genotypes of HBV are diversely found in high and low incidence areas. Regardless of documented strong associations between TP53 R249S mutation and HBV genotypes B, C, A or E, there is no report of such association for genotype D despite of the presence of aflatoxin in areas with high prevalence of HBV genotype D. In Iran, 3% of the population is chronically infected with HBV, predominantly genotype D. Twenty-one histologically confirmed HCC cases from Iran were analyzed for TP53 R249S and HBV double mutations 1762 T /1764 A , hallmarks of more pathogenic forms of HBV. We did not detect any of these mutations. In addition, we report the only case identified so far carrying both R249S mutation and chronic HBV genotype D, a patient from The Gambia in West Africa. This paper suggests that association between HBV genotype D and aflatoxin-induced TP53 mutation is uncommon, explaining the relatively lower incidence of HCC in areas where genotype D is highly prevalent.

Autor:innen und Institutionen

  • Mechanisms of Carcinogenesis Section, Molecular Carcinogenesis Group, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon, France.

Zitieren

APA

Abedi-Ardekani, B., Gouas, D., Villar, S., Sotoudeh, M., & Hainaut, P. (2011). TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S Mutations. Hepatitis Research and Treatment. https://doi.org/10.1155/2011/475965

Vancouver

Abedi-Ardekani B, Gouas D, Villar S, Sotoudeh M, Hainaut P. TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S Mutations. Hepatitis Research and Treatment. 2011. doi:10.1155/2011/475965

BibTeX
@article{AbediArdekani2011,
  author = {Abedi-Ardekani, Behnoush and Gouas, Doriane and Villar, Stephanie and Sotoudeh, Masoud and Hainaut, Pierre},
  title = {TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S Mutations},
  journal = {Hepatitis Research and Treatment},
  year = {2011},
  doi = {10.1155/2011/475965}
}
Kostenlos starten →